One-year Outcomes of ACURATE neo2 vs Approved TAVR Devices in All-risk patients with Severe AS: the ACURATE IDE Trial

Within the prior 24 months, I have had a financial relationship with a company producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients:

• Consultant Fee/Honoraria/Speaker's Bureau - Medtronic; Boston Scientific Corporation; W.L. Gore & Associates; Abbott
• Advisory Board - JValve; High Life; BSCI; Medtronic; WLGore